The following is the second of two letters which appeared in the scientific journal Nature in 1987 (1):
Sir, You recently published a letter (2) in which I argued that progress in AIDS research is being delayed because the present system of funding is inhibiting collaboration between researchers. I reported that after I had responded positively to requests for samples of my cDNA recombinants from various US laboratories engaged in AIDS-related research, my research grant applications were rejected by three major funding organizations (US and Canadian). Specifically, a Canadian organization gave as a major reason for refusing funding the fact that I had shared my recombinants.
I now have the official summary statement from the US National Institutes of Health (NIH), giving reasons why that organization also rejected my application. One of the criteria used to assess applications from foreign laboratories is whether there is anything unique about the laboratory that could not be